CSN Login
Members Online: 6

IDH1 Development

dmercer1
Posts: 16
Joined: Mar 2011

Anyone else see this? Pretty exciting.

http://www.webwire.com/ViewPressRel.asp?aId=180575#.UkMGNbx5iqQ

I_Promise's picture
I_Promise
Posts: 210
Joined: Aug 2011

for sharing this info. I had not seen it. What is interesting is that the drug used 5-azacytidine is already an FDA approved drug for other cancers. So I guess an oncologist could always prescribe it off label if she/he wanted to... Of course you need to carry the mutation IDH1 mutation (present in 70-80% of low grade gliomas) to use this new drug. I hope they fast forward a clinical trial.

J.

 

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network